Galera to Present at Jefferies Healthcare Conference
June 02 2022 - 7:00AM
Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage
biopharmaceutical company focused on developing and commercializing
a pipeline of novel, proprietary therapeutics that have the
potential to transform radiotherapy in cancer, today announced that
Mel Sorensen, M.D., President and Chief Executive Officer, will
present at the 2022 Jefferies Healthcare Conference on Thursday,
June 9, 2022 at 2:00 p.m. E.T.
A live webcast of the presentation will be accessible from the
Investors page of Galera’s website, investors.galeratx.com. An
archived version of the webcast will be available in the Events
& Presentations section of the Investors page of Galera’s
website for 30 days following the event.
About Galera TherapeuticsGalera Therapeutics,
Inc. is a clinical-stage biopharmaceutical company focused on
developing and commercializing a pipeline of novel, proprietary
therapeutic candidates that have the potential to transform
radiotherapy in cancer. Galera’s selective dismutase mimetic
product candidate avasopasem manganese (GC4419, also referred to as
avasopasem) is being evaluated for radiotherapy-induced toxicities.
The Company’s second product candidate, rucosopasem manganese
(GC4711, also referred to as rucosopasem), is in clinical-stage
development to augment the anti-cancer efficacy of stereotactic
body radiation therapy in patients with non-small cell lung cancer
and locally advanced pancreatic cancer. Galera is headquartered in
Malvern, PA. For more information, please visit
www.galeratx.com.
Investor Contacts:Christopher DegnanGalera
Therapeutics, Inc.610-725-1500cdegnan@galeratx.com
William WindhamSolebury
Trout646-378-2946wwindham@soleburytrout.com
Media Contact:Zara LockshinSolebury
Trout646-378-2960zlockshin@soleburytrout.com
Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
From Sep 2023 to Sep 2024